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Cholesterol biosynthesis in somatic cells is controlled at the transcriptional level by a homeostatic feedback
pathway involving sterol regulatory element binding proteins (SREBPs). These basic helix-loop-helix (bHLH)-
Zip proteins are synthesized as membrane-bound precursors, which are cleaved to form a soluble, transcrip-
tionally active mature SREBP that regulates the promoters for genes involved in lipid synthesis. Homeostasis
is conferred by sterol feedback inhibition of this maturation process. Previous work has demonstrated the
expression of SREBP target genes in the male germ line, several of which are highly up-regulated during
specific developmental stages. However, the role of SREBPs in the control of sterol regulatory element-
containing promoters during spermatogenesis has been unclear. In particular, expression of several of these
genes in male germ cells appears to be insensitive to sterols, contrary to SREBP-dependent gene regulation in
somatic cells. Here, we have characterized a novel isoform of the transcription factor SREBP2, which is highly
enriched in rat and mouse spermatogenic cells. This protein, SREBP2gc, is expressed in a stage-dependent
fashion as a soluble, constitutively active transcription factor that is not subject to feedback control by sterols.
These findings likely explain the apparent sterol-insensitive expression of lipid synthesis genes during sper-
matogenesis. Expression of a sterol-independent, constitutively active SREBP2gc in the male germ line may
have arisen as a means to regulate SREBP target genes in specific developmental stages. This may reflect
unique roles for cholesterol synthesis and other functional targets of SREBPs during spermatogenesis.
Spermatozoa are highly specialized cells that are formed in
the testis through a complex series of developmental stages
that can be grouped into three phases: mitotic, meiotic and
spermiogenic. Spermatogonial cell types constitute the initial
proliferative phase, giving rise to early spermatocytes, which in
turn undergo multiple meiotic steps resulting in haploid round
spermatids. Finally, spermatids morphologically differentiate
into sperm during spermiogenesis. These various events re-
quire the elaboration of a well-coordinated developmental
program of both cell type- and stage-dependent gene expres-
sion (10). Recent studies have begun to identify certain key
regulators of these events. For example, the germ cell-specific
transcription factor CREM is expressed in round spermatids
and is required for completion of spermiogenesis (5, 28). How-
ever, in general, the mechanisms controlling the cellular spec-
ificity and proper timing of gene expression in developing male
germ cells remain poorly understood.
In order to explore transcriptional programs controlling
spermatogenesis, we have previously examined the cell- and
stage-specific regulation of the male germ line proenkephalin
promoter in rodents (14, 27). This promoter is expressed ex-
clusively by spermatogenic cells and is highly up-regulated in
pachytene spermatocytes and haploid round spermatids (55).
We previously identified a regulatory region (GCP1) within the
proximal 5-flanking region of this promoter that is required
for its germ cell-specific expression. GCP1 contains two novel
direct repeat elements (CTCCAG) that are necessary for pro-
moter activity in vivo. Furthermore, a 50- to 55-kDa protein
termed “PACH1” has been identified, which binds specifically
to the GCP1 repeats and is unique to spermatogenic cells (26).
PACH1 is expressed during meiosis and in early haploid cells
with the same developmental pattern during spermatogenesis
as the proenkephalin germ line promoter.
Cholesterol is required for numerous cellular processes, in-
cluding plasma membrane structure and signaling, and as a
precursor for steroids and bile acids (42, 44). It also has a
central role in fertilization, where its concentrations in the
outer sperm membrane appear to regulate capacitation (9). In
somatic cells, synthesis of cholesterol and fatty acids is under
the control of a family of transcription factors termed “sterol
regulatory element binding proteins” (SREBPs). This family
consists of three previously identified proteins: SREBP1a and
SREBP1c, generated from a common gene by alternative pro-
moter usage and splicing; and SREBP2 (6, 34). These proteins
regulate the expression of genes involved in lipid synthesis by
binding to sterol regulatory elements (SREs) present within
their promoters. SREBP2 plays a predominant role in regulat-
ing cholesterol biosynthetic genes, while SREBP1 is more se-
lective for targets involved in fatty acid synthesis (17, 35). Each
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SREBP is synthesized as a membrane-bound, 125-kDa precur-
sor (SREBPp), which is first transported from the endoplasmic
reticulum to the Golgi apparatus via its binding to sterol cleav-
age-activating protein (SCAP) (6). It is then proteolytically
processed within the Golgi apparatus by two distinct proteases
(Site 1 and Site 2), to release a soluble, transcriptionally active
mature form into the cytoplasm (6). This active form is able to
enter the nucleus and regulates SRE-containing promoters.
SREBPs are subject to feedback inhibition by sterols, which
serves to restrict cholesterol concentrations within a range
sufficient to maintain cellular functions without being cyto-
toxic. Sterols act by blocking the SCAP-dependent transport of
SREBPp from the endoplasmic reticulum to the Golgi appa-
ratus, thereby inhibiting formation of the active transcription
factor (32).
While the role of SREBPs in the homeostatic control of
cholesterol and fatty acid synthesis in somatic cells is clearly
established, their function in spermatogenic cells has been less
certain. In particular, previous findings have suggested that
expression of cholesterol biosynthetic genes during spermato-
genesis was determined by SREBP-independent mechanisms
(38). In our efforts to clone PACH1, we have isolated the
cDNA for a unique isoform of SREBP2. This novel protein,
termed “SREBP2gc,” is highly enriched in meiotic spermato-
cytes and haploid round spermatids. It is translated as a trun-
cated, soluble transcription factor that bypasses the proteolytic
processing/sterol feedback pathway and is thus constitutively
active. The implications of the expression of this sterol-insen-
sitive SREBP during spermatogenesis and the relationship be-
tween SREBP2gc and PACH1 are discussed.
MATERIALS AND METHODS
Cloning of GCP1-binding proteins. A gt11 cDNA library from adult rat testis
(Clontech, Palo Alto, Calif.) was screened for PACH1 DNA binding activity with
a concatenated GCP1 DNA probe. A double-stranded GCP1-32 monomer con-
taining the two repeats (CTCCAG) (27) and BamHI 5 overhangs was generated
by annealing the complementary oligodeoxynucleotides (ODNs) GATC
CGAACTCCAGTGTTCGCTCCAGAATCTTGCCC and GATCGGGCAA
GATTCTGGAGCGAACACTGGAGTTCG (repeats are underlined). The
monomer duplex was end labeled with [-32P]ATP and then self-ligated to
generate a concatenated probe consisting mainly of approximately six copies of
GCP1-32. Southwestern assays confirmed that the concatenated probe bound to
the same spermatogenic cell nuclear protein as the monomer (data not shown).
A concatenated GCP1-32mut probe with mutations in the two GCP1 repeat
elements was generated in the same way with the ODNs GATCCGAATA
CAGTTGTTCGTACAGTAATCTTGCCC and GATCGGGCAAGATTACT
GTACGAACAACTGTATTCG. This mutated probe did not bind to PACH1 on
Southwestern blots (data not shown). Protein replica filters were prepared and
screened for expression of DNA binding activity by using Y1090 cells. Briefly,
plaques were transferred onto Duralose-UV membranes (Stratagene, La Jolla,
Calif.) and induced with isopropyl--D-thiogalactopyranoside (IPTG) at 37°C.
Proteins were denatured and renatured at 4°C in HEPES binding buffer (HBB:
25 mM HEPES [pH 7.9], 25 mM NaCl, 5 mM MgCl2, 0.5 mM dithiothreitol
[DTT]) with sequential dilutions of guanidinium-HCl. The transfer membranes
were incubated with 5% nonfat dry milk in HBB for 1 h and then with HBB
containing 2  106 cpm of 32P-labeled probe per ml and freshly sonicated salmon
sperm DNA (0.8 g/ml) overnight at 4oC. Membranes were then washed at 4°C
with HBB and submitted to autoradiography. After screening of 5  106 plaques
with the wild-type GCP1 probe, positive clones were screened with the GCP1mut
probe to eliminate nonspecific DNA binding proteins. DNA sequencing of rel-
evant clones was performed by the dideoxy chain-termination method on an
Applied Biosystems model 377 DNA sequencer.
5 and 3 RACE PCR for rat SREBP2gc cDNA. Total RNA from enriched rat
spermatogenic cells was amplified with a Gene Racer kit (Invitrogen, Carlsbad,
Calif.). Sequence-specific primers and the universal primers supplied by the
manufacturer were used to extend the 5 and 3 ends. Specific 5 rapid amplifi-
cation of cDNA ends (RACE) primer 1 (AGCTTTCAAGTCCTGCAGCCT
CAAG) and 5 RACE primer 2 (AGACGGTGATGATCACCCCGACCT)
were used for the initial and nested steps, respectively, to generate 5-end
sequences, while 3 RACE primer 1 (AGCTCCTGAAGGGCATCGACT) and
3 RACE primer 2 (GTATGAGCTTCGACATTTCTCACACTC) were used for
3 sequences. The PCR products were subcloned into pCR4-TOPO vector for
sequencing with the TOPO TA cloning kit (Invitrogen).
RT-PCR. Total RNAs from spermatogenic cells and tissues were analyzed by
using the Titan One-Step reverse transcription-PCR (RT-PCR) kit (Roche Ap-
plied Science, Indianapolis, Ind.). The following primers were used: BP2-1 (AT
CATTGAGAAGCGGTACCGGTC), BP2-2 (AAGTCGATGCCCTTCAG
GAGCTT), and BP2gc (GTTCAGAGTGTGAGAAATGTCGAAGCTCA).
Preparation of enriched and purified testicular cells. Adult male germ cells
enriched in pachytene spermatocytes and round and condensing spermatids were
prepared from rat and mouse testes by enzymatic digestion essentially according
to the method of Bellve et al. (4). Purified spermatogenic cell types were pre-
pared from either immature or mature mouse testes by unit gravity sedimenta-
tion, as previously described (3, 4). The purities of various germ cell types ranged
from 89 to 96%. Sertoli cells were prepared from 19- to 21-day-old rat testes by
similar procedures (31), and spermatozoa were isolated from adult mouse epi-
didymis by mincing in the presence of phosphate-buffered saline (PBS) and then
filtration through 50-m-pore-diameter nylon mesh.
RNA extraction and Northern blots. Total RNA was extracted from tissues
and cells by using Tri-Reagent (Sigma, St. Louis, Mo.). In general, cDNA probes
were labeled with [	-32P]dCTP by using the Prime-a-Gene labeling system (Pro-
mega, Madison, Wis.). For rat SREBP2gc mRNA mapping studies, probe I was
generated from the rat SREBP2gc cDNA by PCR with the primers 5-UTR (5
untranslated region) (CGTCTCCCTGAGCTGGACCTCA) and E1 (CTCGTC
GATGTCCCCGAGAGT). The PCR product was then used as a template to
synthesize a 32P-labeled antisense strand probe with Klenow fragment and
primer E1. For probe II, an EcoRI fragment was prepared from SREBP2gc
cDNA, while the 3 RACE PCR product was used for probe III. Twenty micro-
grams of total RNA was run on formaldehyde-containing agarose gels and
transferred to Gene Screen Plus membranes (NEN Life Science, Boston, Mass.).
Equivalency of loading and transfer was verified by ethidium bromide staining.
Membranes were hybridized with DNA probes (2  106 cpm/ml) as described
previously (21).
Polysome analysis. The procedure for polysome fractionation of mouse tes-
ticular mRNA was performed as previously described (20). Briefly, a postnuclear
fraction was separated on sucrose gradients in buffer (20 mM HEPES [pH
7.6],100 mM KCl, 0.5%Triton X-100, 3 mM -mercaptoethanol, 300 U of RNA-
sin per ml) containing either 20 mM MgCl2 (HKM) or 10 mM EDTA (HKE),
with the latter used for negative control gradients because EDTA disrupts
polysomes. Following RNA extraction, equal percentages of gradient fractions
were submitted to Northern analysis.
Protein extraction and Western blotting. Nuclei were isolated from cell frac-
tions and tissues and extracted as previously described (27). Briefly, samples were
homogenized in buffer A (10 mM HEPES [pH 8.0], 1.5 mM MgCl2, 10 mM KCl,
1 mM EDTA, 1 mM EGTA, 5 mM DTT, 0.1 mM phenylmethylsulfonyl fluoride
[PMSF], 1 protease inhibitor cocktail mix [Boehringer Mannheim, Indianap-
olis, Ind.], 25 g of N-acetyl-Leu-Leu-Nle-CHO [ALLN] per ml, 0.5% NP-40).
Nuclei were centrifuged at 3,000  g for 3 min at 4°C, and the supernatant was
used for cytoplasmic proteins. Nuclei were extracted in NEB (20 mM HEPES
[pH 8.0], 25% glycerol, 0.4 M NaCl, 0.2 mM EDTA, 1 mM DTT, 0.1 mM PMSF,
protease inhibitor mix, ALLN) on ice for 30 min. Microsomes were prepared by
homogenization in buffer A without NP-40 and centrifugation of the postnuclear
supernatant at 100,000  g for 1 h. Following washing, the membrane pellet was
solubilized by resuspension in a mixture containing 10 mM Tris-HCl (pH 6.8), 0.1
M NaCl, and 1% (vol/vol) sodium dodecyl sulfate (SDS) and boiled for 5 min
prior to electrophoresis.
Protein extracts were separated on 8% SDS-polyacrylamide gels and trans-
ferred onto polyvinylidene difluoride (PVDF) transfer membranes (Millipore,
Bedford, Mass.). The buffer used for dilution of antibodies and the blocking step
was 1 PBS buffer with 0.1% Tween 20 and 10% nonfat dry milk. The blocking
step was performed at 4°C overnight. Bound antibodies were detected with a
Western Lightning Chemiluminescence kit (Perkin-Elmer Life Science, Boston,
Mass.) according to the manufacturer’s protocol. Rabbit polyclonal antibodies
against mouse SREBP2 (residues 1 to 100) and monoclonal antibodies to ham-
ster SREBP2 (immunoglobulin G [IgG]-7D4) (53) were kindly provided by J.
Horton; polyclonal antibodies to human SREBP2 (residues 1 to 481) (40) were
obtained from Ryuichiro Sato. Rabbit polyclonal antibodies made to human
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SREBP1 (K-10) that react with both precursor and mature forms of SREBP1
were obtained from Santa Cruz Biotech (Santa Cruz, Calif.).
Southwestern assays. For Southwestern blotting, nuclear extracts were sepa-
rated on 8% SDS–polyacrylamide gels and then transferred onto Duralose-UV
membranes. Protocols for blocking, binding, and washing steps were as described
for cDNA library screening.
EMSAs. For electrophoretic mobility shift assays (EMSAs), nuclear extracts
were assayed under conditions used in earlier studies (27). Double-stranded
ODNs containing 5 overhangs were labeled with [	-32P]dCTP by fill-in reaction
with Klenow fragment. DNA probes consisted of GCP1 and GCP1mut se-
quences (27) and SRE-1 (GATCATCACCCCACTGCA) and SRE-1mut
(GATCTGATAAGATATGCA) (core SRE sequence or its mutations are un-
derlined).
Plasmid DNA constructs, bacterial expression, and cell transfection. The rat
SREBP2gc coding region was released from the  phage DNA by EcoRI diges-
tion and subcloned into pBluescript to generate pBS-RBP2gc for sequencing.
The EcoRI fragment was also inserted in frame into pGEX-4T1 expression
vector (Phamacia) to create pGEX-RBP2gc for bacterial expression. BL21(DE3)
bacteria were transformed with this vector or with empty pGEX-4T1 plasmid and
induced with 0.1 mM IPTG. For mammalian expression, the full-length rat
SREBP2gc cDNA was first generated by combining the 5 sequence obtained by
5 RACE PCR with the pBS-RBP2gc sequence via an internal Blp1 site. The
full-length rat SRBP2gc coding sequence was then removed by EcoRI and MscI
digestion and ligated into the EcoRI and SmaI sites of pCMV7 to generate
pCMV-BP2gc. A truncated, constitutively active human SREBP2 protein (resi-
dues 1 to 468) in pCMV7 vector was kindly provided by J. Horton. The following
luciferase promoter constructs were created. pLDLR contained the human low-
density lipoprotein (LDL) receptor (LDLR) promoter inserted into pGL2 (a gift
from J. Horton). pCYP51 contained the human CYP51 promoter inserted into
pGL2 (38) (a gift from D. Rozman). Finally, pRPKLuc-0.5 consisted of a 500-bp
rat proenkephalin germ line promoter fragment derived from pRPKCAT0.5 (27)
inserted into pGL3. DNAs for promoter constructs (0.5 g), expression vectors
(10 ng) and pCMV--galactosidase normalization control plasmid (50 ng) were
cotransfected into human K293 cells by using Trans-Fast transfection reagent
(Promega) and analyzed 40 to 48 h later with commercial kits for luciferase
(Promega) and -galactosidase (Tropix, Bedford, Mass.).
Sterol-depletion studies. Mouse preadipocyte 3T3-L1 cells were incubated at
37°C with 5% CO2 in Dulbecco’s modified Eagle’s medium (DMEM) containing
10% fetal calf serum (FCS) and penicillin-streptomycin (pen-strep [100 U/ml]).
Upon 70 to 80% confluency, the medium was changed to DMEM–pen-strep
containing 5% lipoprotein-deficient fetal bovine serum (LPDS), 50 M compac-
tin, and 50 M sodium mevalonate, without (sterol depleted) or with (sterol
loaded) 10 g of cholesterol and 1 g of 25-hydroxycholesterol per ml, and cells
were cultured for an additional 9 h. One hour prior to cell harvest, 25 g of
ALLN protease inhibitor per ml was added.
Short-term culturing of spermatogenic cells was performed as previously de-
scribed (15). Following two differential plating steps, enriched spermatogenic
cells from adult mice were cultured in DMEM plus 10% FCS, pen-strep, 1 mM
lactate, and 1% nonessential amino acids in 5% CO2 at 33°C. For sterol-deple-
tion studies, cells were incubated for 9 h in the medium described above, in which
serum was replaced with either sterol-depleted or sterol-loaded components, as
described for 3T3-L1 cells.
RESULTS
Cloning and analysis of SREBP2gc. In attempting to clone
the cDNA for PACH1, we screened an expression cDNA li-
brary from rat testis with wild-type and mutated GCP1 con-
catemers as positive- and negative-selection probes (see Ma-
terials and Methods). One of the clones exhibiting robust and
GCP1 repeat-dependent binding was characterized further.
DNA sequencing revealed a partial cDNA that was highly
related to hamster and human SREBP2 (18, 54). The complete
coding sequence as well as 5- and 3-UTRs were subsequently
generated by RACE RT-PCR (Fig. 1). This cDNA, which we
have named SREBP2gc for “germ cell enriched form” (de-
scribed below), encodes a shortened N-terminal portion of the
SREBP2 precursor protein. This includes the conserved tran-
scriptionally active portion consisting of the basic helix-loop-
helix (bHLH)-Zip (DNA binding, dimerization, and nuclear
localization signal) and N-terminal acidic transactivation do-
mains, but it lacks the membrane-spanning and SCAP binding
domains (Fig. 2). SREBP2gc thus is very similar to the mature,
proteolytically processed form of SREBP2, which is ubiqui-
tously expressed in somatic cells. One difference relative to the
mature form is the absence of 20 amino acid residues from the
C terminus of SREBP2gc (Fig. 2 and 3A).
The SREBP2gc protein sequence is highly homologous to
the corresponding regions of SREBP2 from other species
(hamster, 94%; human, 90%; mouse, 94%), especially within
the bHLH-Zip and transactivation domains. The greatest vari-
ability occurs within the Gly/Ser- and Gln/Pro-rich regions
adjacent to the acidic transactivation domain, which also vary
in length and/or sequence among mammalian SREBP2s (Fig.
3A). The 5-UTR of SREBP2gc also shares significant homol-
ogy with those for previously characterized SREBP2 cDNAs
(data not shown), while the 3-UTR is, in general, divergent
(described below). Two potential polyadenylation sequences
that are commonly used in spermatogenic, but not somatic,
cells (52) were identified upstream of the poly(A) tail (Fig. 1).
Interestingly, another SREBP2 isoform was previously iden-
tified in a sterol-resistant, mutant cell line (SRD-3) that is also
synthesized as a truncated protein and lacks 20 amino acid
residues present at the C terminus of the ubiquitous mature
form (53) (Fig. 3A). This mutant cell line was generated from
Chinese hamster ovary cells by mutagenesis followed by selec-
tion for sterol resistance. The SRD-3 mutant protein appar-
ently arose by selective genomic amplification of only certain
exons and introns, generating an mRNA with an unspliced
intron sequence starting at the C-terminal Val/stop codon lo-
cation (Fig. 3B) (53). The first 40 bp of the 3-UTR of
SREBP2gc is 85% identical to the corresponding 3-unspliced
intron sequence of the SRD-3 isoform, including an apparent
consensus 5 splice site (Fig. 3B). It is therefore highly proba-
ble that SREBP2gc is generated by alternative splicing in rat
testis. SRD-3 mutant cells are sterol resistant due to the unique
properties of the truncated SREBP2 mutant protein they ex-
press: namely, a soluble, constitutively active transcription fac-
tor not subject to feedback inhibition by sterols (53). Based on
their essentially identical protein sequences, SREBP2gc is pre-
dicted to share these properties, being able to enter the nu-
cleus and constitutively regulate target promoters in expressing
cells independent of sterol concentrations.
Analysis of SREBP2 mRNAs in testis and spermatogenic
cells. To examine the expression patterns of SREBP2 tran-
scripts in rat and mouse tissues, we first performed RT-PCR
studies. Primer pairs were designed that would generate either
a 218-bp PCR product from both the SREBP2p and
SREBP2gc RNAs or that spanned the 3-UTR, splice junction,
coding region of SREPBP2gc and would generate a unique
401-bp product (Fig. 4A). The common, 218-bp RT-PCR
product was detectable in rat somatic tissues, testis, and en-
riched adult spermatogenic cells (consisting mainly of
pachytene spermatocytes, round spermatids, condensing sper-
matids, and their cytoplasmic fragments) (Fig. 4A). However,
the SREBP2gc-specific product was detected only in adult rat
germ cells. Sequencing of the latter PCR product showed that
it was identical to the predicted coding region of SREBP2gc
(data not shown). A similar series of RT-PCR experiments
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demonstrated the presence of SREBP2gc transcripts in mouse
testis and adult male germ cells as well, but not in mouse
somatic tissues, such as liver (data not shown). These results
thus confirmed that SREBP2gc transcripts are preferentially
enriched in adult spermatogenic cells.
Northern analysis revealed two major RNA bands in rat
testis and enriched adult male germ cells, 
5 and 3 kb in size
(Fig. 4B and C). The 
5-kb band corresponded to the ubiq-
uitous transcript for the SREBP2 precursor protein and was
actually resolvable into two species of 5.2 and 4.2 kb (Fig. 4C),
as previously described for human SREBP2 mRNAs (18). The
4.2-kb transcript may arise from the use of an alternative poly-
adenylation site within the SREBP2 gene (18). These RNAs
were detected in rat somatic tissues, including lung, liver,
brain, kidney (not shown), and Sertoli cells (Fig. 4B). The 3-kb
transcript was not detected in any rat somatic tissues examined,
and its size agrees well with that of the rat SREBP2gc cDNA.
FIG. 1. Nucleotide and amino acid sequences of rat SREBP2gc cDNA. The numbers to the left refer to the positions of nucleotides and amino
acids. The box denotes the conserved bHLH-Zip region, and the acidic N-terminal transactivation domain is underlined. The dashed lines indicate
the primers used for 5 and 3 RACE-PCR. The dashed-lined boxes indicate potential germ cell-specific polyadenylation signals (52).
FIG. 2. Schematic structures for different forms of SREBP2. Var-
ious domains are indicated as follows: acidic N-terminal transactiva-
tion domain (TA); serine- and glycine-rich (S) domain, as well as
glutamine-rich (Q) domain; conserved bHLH-Zip DNA binding do-
main (bHZ); transmembrane domain (TM); and regulatory SCAP-
binding domain (RSB). A 20-amino-acid sequence missing from the C
terminus of SREBP2gc is also indicated by a small open box.
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FIG. 3. Comparison of sequences for rat SREBP2gc and SREBP2 from other species. (A) Protein sequences for SREBP2 from the mutant,
sterol-resistant hamster cell line SRD-3 (haSRD-3) (53); rat SREBP2gc (rSREBP2gc); mature human SREBP2 (hSREBP2) (18); and the
predicted mature form of mouse SREBP2 (mSREBP2), based on GenBank sequences (accession no. AAK54763) (Note that these sequences are
incomplete at the N terminus.) Symbols below the amino acid sequences indicate the following relationships among different species: asterisks,
identical amino acids; colons, high similarity; dots or open spaces, poor or no similarity, respectively. (B) Comparison of nucleotide sequences
spanning the unique 3-UTR, splice junction, and coding regions for rat SREBP2gc and SREBP2 from hamster SRD-3 cells. The 5-splice sequence
is underlined, and the stop codon is shown by an asterisk.
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Analysis of mouse tissues showed a similar expression pattern:
both 5.2- and 4.2-kb SREBP2p mRNAs were present in all
somatic tissues tested, and a unique, smaller form (
2.5 kb)
was the predominant transcript in mouse testis and adult sper-
matogenic cells (Fig. 4C and D). Trace amounts of the 2.5-kb
RNA also were detected in mouse ovary (Fig. 4C) and brain
(Fig. 4D), but not in other tissues. The smaller transcript ob-
served in mouse ovary also may be of germ cell origin. In
contrast to the rat, the two larger SREBP2 mRNAs were
greatly reduced in mouse testis and adult male germ cells
relative to somatic tissues, and the 4.2-kb transcript was more
abundant than the 5.2-kb mRNA (Fig. 4C). Thus, both rat and
mouse spermatogenic cells contain a novel, shorter SREBP2
transcript that is undetectable or present at very low levels in
somatic tissues.
The results presented above suggested that the shorter
RNAs enriched in the adult rat and mouse spermatogenic cells
contained SREBP2gc sequences. To confirm this, RNA-map-
ping studies were performed with probes to three different
portions of the rat SREBP2gc cDNA: the 5-UTR and exon I
region shared by both the SREBP2p and SREBP2gc RNAs
(probe I), the common coding region and unique 3-UTR
(probe II), and the 3-UTR sequences unique to SREBP2gc
transcripts (probe III). While probes I and II hybridized to
both the SREBP2p mRNAs as well as the unique 3-kb tran-
script in rat testis and spermatogenic cells, probe III hybridized
only to the germ cell-enriched 3-kb transcript (Fig. 5). We
conclude that this shorter novel RNA encodes rat SREBP2gc.
The novel 2.5-kb RNA in mouse adult spermatogenic cells also
presumably corresponds to the SREBP2gc transcript based on
its predominance and expression pattern in these cells (Fig.
4C) (also described below).
SREBP2gc RNA is translated. To address the expression of
SREBP2gc protein in male germ cells, we first examined the
translational status of its mRNA. Polysomal analysis was per-
formed for SREBP2 transcripts in mouse testis by using su-
crose gradient fractionation in the absence or presence of
EDTA, which disrupts polysome integrity (Fig. 6A). In gen-
eral, mRNAs in adult male germ cells are only partially asso-
ciated with large polysomes (denser gradient fractions) due to
a lower overall translation efficiency than is typically found for
somatic mRNAs (23). Such a partial polysomal distribution
was observed for both the 5.2- or 4.2-kb RNA and the 2.5-kb
SREBP2 RNA, the percentage being somewhat higher for the
FIG. 4. SREBP2 transcripts in rat and mouse tissues and male
germ cells. (A) RT-PCR analysis. Two micrograms (each) of total
RNA from adult rat spermatogenic cells (G), liver (L), and fat tissue
(F) was analyzed. pBS-RBP2gc plasmid DNA was used as a positive
control (). No-RNA template and no-reverse transcriptase reactions
served as negative controls (). M, DNA size ladder. Shown are the
218-bp DNA fragment derived from SREBP2 mRNAs by using prim-
ers BP2-1 and BP2-2 (lanes to the left of size marker) and the 401-bp
SREBP2gc-specific product generated with primers BP2-1 and BP2gc
(lanes to the right of the size marker). (B, C, and D) Northern analysis
of SREBP2 mRNAs with rat SREBP2gc cDNA as a probe. Twenty
micrograms of total RNA was analyzed in each lane. (B) Rat liver (Li),
lung (Lu), brain (Br), testis (Te), and enriched spermatogenic cells
from adult testis (Gc). The same blot was probed for SREBP2gc (top)
and rat proenkephalin (bottom) transcripts. RNA loading in the rat
germ cell lane was reduced relative to rat testis, as shown by the lower
signal for the germ cell-specific proenkephalin transcript (22) in this
lane. (C) Mouse ovary (Ov), enriched adult mouse spermatogenic cells
(Gc), mouse testis (Te), rat Sertoli cells (St), and rat testis (Te).
(D) Analysis of multiple adult mouse tissues, as indicated. The results
of ethidium bromide staining of 28S and 18S RNAs on the blot are
shown below.
FIG. 5. Identification of SREBP2gc RNA in rat spermatogenic
cells. Twenty micrograms (each) of total RNA from rat brain (B), testis
(T), and enriched adult rat spermatogenic cells (G) was examined. The
positions of probes derived from the SREBP2gc cDNA are shown
schematically below the Northern results. Solid lines show sequences
common to the SREBP2p and SREBP2gc RNAs, while the dotted
lines indicate sequences unique to the SREBP2gc transcript. eI, pre-
sumptive exon I region based on sequence homology with the hamster
SREBP2 gene.
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two larger SREBP2p mRNAs (Fig. 6A). This slightly greater
polysomal enrichment for the 5.2- and 4.2-kb mRNAs was
expected based on the fact that the concentrations of these
transcripts are greatly reduced in adult male germ cells of the
mouse (Fig. 4C), such that contributions by the more efficiently
translated mRNAs in testicular somatic cells (e.g., Sertoli, peri-
tubular, and Leydig cells) are apparent. The distribution of the
germ cell-enriched 2.5-kb mRNA in the denser gradient frac-
tions is very similar to that for most other mRNAs translated
in adult spermatogenic cells, such as LDH-C and Sp1 (7, 23,
36). Thus, SREBP2gc mRNA is actively translated in mouse
adult male germ cells at levels typical of mRNAs expressed
during spermatogenesis.
Spermatogenic cells express a novel SREBP2 protein. Im-
munoblots were performed to determine the nature of
SREBP2 proteins in male germ cells of the mouse and rat. As
noted earlier, in somatic cells, SREBP2 is synthesized as a
125-kDa precursor, which is then cleaved to release the mature
form, which typically runs as a 66-kDa protein on SDS gels
(53). However, the levels of the mature protein are generally
very low in tissues under normal conditions due to feedback
inhibition by sterols. In microsomes, an 
125-kDa protein was
detected in mouse somatic tissues and spermatogenic cells
corresponding to the SREBP2 precursor, although the levels
were greatly reduced in male germ cells (Fig. 6B, left panel).
The latter result is consistent with the very low levels of
SREBP2p mRNAs in this cell fraction (Fig. 4C). In contrast,
nuclear extracts from adult rat and mouse spermatogenic cells
contained abundant amounts of an SREBP2-related protein of

55 kDa, while no protein was detected in nuclear extracts
from somatic tissues (Fig. 6B, right and lower panels). It
should be noted that an identical 55-kDa protein was detected
by three different SREBP2 antibodies (see Materials and
Methods). As a control, extracts were also analyzed from
mouse 3T3 cells cultured under sterol-depleted conditions,
which induce SREBP2 precursor processing to form the ma-
ture protein (19). Western blotting confirmed that the sper-
matogenic cell protein runs 
11 kDa smaller on SDS gels than
mouse somatic SREBP2 (
66 kDa) (Fig. 6C). The apparent
size of SREBP2gc from SDS gels is larger than predicted based
on its composition (48.6 kDa). The same is true for the 66-kDa,
mature somatic form of SREBP2 (24, 53), which in the mouse
has a theoretical mass of 51.4 kDa.
Immunoblots also showed that the 55-kDa germ cell protein
was present in nuclear but not cytoplasmic fractions of adult
mouse spermatogenic cells (Fig. 6D). This finding is consistent
with the predicted properties of SREBP2gc as a soluble tran-
scriptional regulator able to directly enter the nucleus.
Spermatogenic cells contain elevated levels of SREBPs. To
examine the nature of SREBPs in male germ cells, Southwest-
ern analysis was performed with the SRE from the human
LDLR promoter (SRE-1) as a DNA probe. No significant
binding was observed with nuclear proteins from mouse so-
matic tissues (Fig. 7A), consistent with the very low levels of
mature SREBPs in these tissues under normal conditions.
However, an abundant SREBP was present in nuclear extracts
of mouse spermatogenic cells that was identical in size to
SREBP2 detected by immunoblots (
55 kDa). This protein
did not bind to DNA in which the SRE-1 core sequence was
mutated (Fig. 7A). These findings indicate that the SREBP2-
related protein detected on Western blots also possesses SRE
binding activity and presumably corresponds to SREBP2gc.
EMSAs detected a single major SRE-1 binding complex in
mouse and rat adult spermatogenic cells that was competed
well by unlabeled SRE-1 sequences, but not by a mutated
SRE-1 competitor (Fig. 7B). Extremely low binding activity
was detected with nuclear extracts from somatic tissues such as
liver (data not shown). It also should be noted that no SREBP1
(precursor or mature forms) was detectable in adult mouse
spermatogenic cells by Western analysis (data not shown),
indicating that all SRE binding activity in spermatogenic cells
derives exclusively from SREBP2gc (note that none of the
available SREBP2 antibodies were able to specifically super-
shift native SREBP2-DNA complexes from rat or mouse).
Based on these various findings, we conclude that rat and
mouse adult male germ cells express a unique SREBP corre-
sponding to SREBP2gc. This protein is predicted to function
as a sterol-independent, constitutively active transcriptional
regulator during spermatogenesis.
FIG. 6. Analysis of SREBP2 mRNA translation and protein prod-
ucts in male germ cells. (A) Polysome analysis. Cytoplasmic RNA from
mouse testis was fractionated in the presence of Mg2 (HKM) or
EDTA (HKE). Equal percentages of total RNA from fractions within
each gradient were examined for SREBP2gc RNA by Northern anal-
ysis. RNA in lane 2 of the HKM gradient was underrepresented due to
partial loss of sample. Gradient orientations are indicated below the
Northern blot results, with larger polysomes localized to the denser
(bottom) fractions. (B) Western analysis of SREBP2 protein in mouse
and rat tissues and spermatogenic cells. (Left panel) Four micrograms
(each) of microsomal protein from enriched adult mouse spermato-
genic cells (G), brain (B), liver (Li), and lung (Lu) was examined.
(Right panel) Analysis of nuclear extracts (5 g) from enriched adult
mouse spermatogenic cells (G), brain (B), kidney (K), and lung (Lu).
(Lower panel) Five micrograms (each) of nuclear extract from en-
riched adult mouse and rat spermatogenic cells (G), mouse liver (Li),
and rat lung (Lu) was examined. (C) Western blot of nuclear extracts
(5 g) from adult mouse spermatogenic cells (G) and sterol-depleted
mouse 3T3-L1 cells (3T3). (D) Analysis of SREBP2gc protein in nuclei
(Nu) and cytoplasmic (Cyt) fractions of adult mouse spermatogenic
cells (5 g per lane).
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Developmental expression of SREBP2gc in male germ cells.
To gain a better understanding of the functional significance of
SREBP2gc, we examined its pattern of expression in purified
spermatogenic cell types. With respect to SREBP2 mRNAs,
the two larger SREBP2p mRNAs were predominant in mitotic
spermatogonial stages, with very little of the 2.5-kb
(SREBP2gc) mRNA detectable (Fig. 8A). In early (prepuber-
tal) and late (adult) pachytene spermatocytes, the SREBP2p
transcripts were reduced in abundance. In contrast, the 2.5-kb
mRNA markedly increased in these stages, and was the major
SREBP2 mRNA in late pachytene spermatocytes. In haploid
round spermatids, the levels of both of the 2.5- and 4.2-kb
mRNAs were noticeably increased, with the 2.5-kb mRNA still
predominant. Only the 2.5-kb mRNA was observed in cyto-
plasts (cytoplasmic fragments derived from condensing sper-
matids).
The pattern for SREBP1 transcripts during mouse spermat-
ogenesis differed markedly from that for SREBP2. Only the
4.1-kb mRNA for the SREBP1 precursor protein (49) was
detected in purified male germ cells, and it declined dramati-
cally in adult pachytene spermatocytes and round spermatids
(Fig. 8B). This result is identical to the pattern for the 5.2-kb
SREBP2p mRNA (Fig. 8A).
Immunoblotting of nuclear extracts from developing mouse
testis was performed to determine the timing of onset for the
55-kDa SREBP2gc protein (Fig. 8C). This protein was first
detected on postnatal day 17, when pachytene spermatocytes
become predominant in mouse testis (3). SREBP2gc protein
increased further by day 21, when round spermatids increase in
numbers, and remained relatively constant thereafter. EMSAs
revealed a similar time course for SRE-1 binding activity in the
developing mouse testis (data not shown). These findings are
consistent with SREBP2gc expression mainly in spermatocytes
and spermatids, but with no significant expression in testicular
somatic cell types, which are more predominant in the imma-
ture testis. Analysis of purified spermatogenic stages confirmed
this pattern (Fig. 8D). SREBP2gc was not expressed in sper-
matogonia, but was readily detected in pachytene spermato-
FIG. 7. Detection of SRE-1 binding proteins in adult mouse sper-
matogenic cells and tissues. (A) Southwestern analysis of nuclear ex-
tracts (5 g) from enriched spermatogenic cells from adult mouse
testis (Gc), brain (B), and liver (Li). Wild-type (SRE-1) and mutant
(mSRE-1) probes were used. (B) EMSA of SREBPs in mouse and rat
spermatogenic cells. Nuclear extracts (1.5 g) were examined for sper-
matogenic cells from adult mouse testis (lanes 2 to 4) and rat testis
(lanes 5 to 7) by using the SRE-1 probe. Lanes: 1, probe only; 2 and 5,
no competitor; 3 and 6, 10-fold excess of unlabeled SRE-1 wild-type
competitor; 4 and 7, 10-fold excess of mutated SRE-1 competitor. The
specific SREBP–SRE-1 complex is shown by an asterisk. The residual
binding seen with the wild-type SRE-1 competitor was specifically
eliminated at larger amounts of competitor (data not shown).
FIG. 8. Developmental expression of SREBP2gc in male germ
cells. (A) Northern analysis of purified mouse spermatogenic cells with
rat SREBP2gc cDNA as a probe. Fifteen micrograms (each) of total
RNA from spermatogonia type A (A), spermatogonia type B (B),
prepubertal pachytene spermatocytes (PP), pachytene spermatocytes
(PS), round spermatids (RS), and cytoplasts (Cy) was examined. Rel-
ative RNA loading is shown below by the ethidium bromide staining of
the blot prior to hybridization. (B) Northern analysis of purified mouse
spermatogenic cells with SREBP1c cDNA as a probe. Fractions are as
in panel A, with the addition of preleptotene spermatocytes (PL), and
the ethidium bromide-stained blot is shown below. (C) Western anal-
ysis of SREBP2gc protein in the developing mouse testis. Five micro-
grams (each) of testis nuclear extracts was examined from the indi-
cated postnatal day mice and adults (Ad). (D) Western analysis of
SREBP2gc protein in purified mouse spermatogenic cells. Five micro-
grams (each) of nuclear extracts from spermatogonia type A (A),
spermatogonia type B (B), pachytene spermatocytes (PS), round sper-
matids (RS), enriched spermatogenic cells from adult mouse testis
(Gc), and mouse sperm (SP) was examined.
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cytes and round spermatids. Interestingly, SREBP2 was unde-
tectable in epididymal sperm, indicating that it is not retained
within spermatozoa during their formation. Thus, the
SREBP2gc transcript and protein are expressed in the same
stage-dependent manner, suggesting a particularly important
role for this protein in transcriptional regulation during mei-
otic and early haploid spermatogenic stages.
SREBP2gc regulates SRE-containing promoters expressed
during late spermatogenesis. To determine the transcriptional
properties of SREBP2gc, we examined its ability to activate
promoters which are expressed during the later phases of sper-
matogenesis. As shown earlier, SREBP2gc recognizes the
SRE-1 site within the promoter for the human LDLR gene.
Further, expression of LDLR mRNA increases with germ cell
maturation during chicken spermatogenesis (25), and in the rat
testis, it increases developmentally with the appearance of late
spermatogenic cell types (29). We therefore cotransfected an
LDLR-luciferase promoter construct together with plasmids
expressing either rat SREBP2gc or the mature form of human
SREBP2 into K293 cells (Fig. 9A). SREBP2gc and mature
SREBP2 stimulated the LDLR promoter 36- and 27-fold, re-
spectively.
The CYP51 gene encodes an enzyme required for the syn-
thesis of 4,4-dimethyl-5	-cholesta-8,14,24-triene-3-ol, an in-
termediate in the formation of cholesterol from lanosterol, and
its promoter is regulated by SREBPs in somatic cells (38). The
CYP51 gene is also expressed in a stage-dependent manner
during spermatogenesis, where it is up-regulated in round
spermatids (45). In cotransfection studies, SREBP2gc stimu-
lated the CYP51 promoter nearly 15-fold, compared with a
9-fold increase induced by mature SREBP2 (Fig. 9B). Thus,
SREPB2gc is a highly potent activator of SRE-containing tar-
get genes expressed during spermatogenesis and thus may have
a critical role in the stage-dependent expression of cholesterol
biosynthetic genes and other potential targets in meiotic and
early haploid spermatogenic cells.
Cell-type-specific regulation of SREBP2gc expression dur-
ing spermatogenesis. Based on its novel structure, SREBP2gc
should be produced in a sterol-independent, constitutive man-
ner in adult male germ cells. To address this question directly,
the effects of sterol levels on SREBP2gc protein were exam-
ined in primary cultures of adult mouse spermatogenic cells
(Fig. 10A). As a control, parallel experiments were also per-
formed with mouse 3T3-L1 cells. The mature, somatic (
66
kDa) SREBP2 protein was not detected in 3T3-L1 cells cul-
tured with cholesterol, but was highly up-regulated under ste-
rol-depleted conditions. In contrast, levels of the 55-kDa
SREBP2gc protein remained unchanged in spermatogenic
cells cultured in the presence and absence of sterols. This
indicates that SREBP2gc is regulated by distinct cell-specific,
cholesterol-insensitive mechanisms during spermatogenesis.
As noted earlier, SREBP2gc protein in mouse and rat germ
cells appears considerably smaller than its 66-kDa somatic
counterpart on SDS gels. This mobility difference cannot be
accounted for solely by the absence of 20 amino acids from the
C terminus of SREPB2gc. Furthermore, mutant SREBP2 from
SRD-3 hamster cells, which lacks the same 20 amino acids and
has a theoretical mass (49.2 kDa) nearly identical to that of
FIG. 9. Transcriptional activity of rat SREBP2gc. K293 cells were
cotransfected with luciferase reporter plasmids for the LDLR pro-
moter (A) or CYP51 promoter (B) and expression vectors for rat
SREBP2gc (pCMV-BP2gc), constitutively active human SREBP2
(pCMV-BP2), or empty pCMV7 parent vector along with pCMV--
galactosidase control plasmid. Data are normalized relative to -ga-
lactosidase activity and are expressed as the fold increase in activity
relative to the activity of the pCMV7 control plasmid. Shown are the
means  standard errors of three independent experiments.
FIG. 10. Cell-type-specific regulation of SREBP2gc expression
during spermatogenesis. (A) Effect of sterols on SREBP2 protein in
mouse 3T3-L1 (3T3) and spermatogenic (mGC) cells. Lanes: 1 and 3,
sterol-depleted culture conditions with compactin and LPDS alone; 2
and 4, sterol-loaded (plus cholesterol) conditions. (B) Size comparison
for SREBP2 proteins from mouse 3T3-L1 cells (3T3), enriched sper-
matogenic cells from adult mouse testis (mGC), and K293 cells trans-
fected with pCMV-BP2gc or pCMV empty vector. Five micrograms
(each) of the nuclear extracts was examined by Western analysis,
except for K293 cell samples (1.2 g).
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SREBP2gc (48.6 kDa), migrates as a significantly larger pro-
tein (
62 kDa) than SREBP2gc on SDS gels (53). These
observations suggested that additional, cell-specific mecha-
nisms may differentially influence the electrophoretic behavior
of SREBP2 in spermatogenic cells. To address this, the elec-
trophoretic mobility of rat SREBP2gc was examined after ex-
pression in a somatic cell line, human embryonic kidney K293
cells (Fig. 10B). Following transfection with expression vector,
K293 cells expressed an SREBP2gc protein that was signifi-
cantly larger (59 kDa) than the endogenous protein in mouse
spermatogenic cells. Thus, significant differences between the
levels of synthesis of SREBP2gc protein occur in spermato-
genic versus nonspermatogenic cells, apparently at the level of
posttranslational modification. The structural basis for this
cell-specific difference in mobility remains to be determined,
although the N-terminal region was previously implicated in
the slower-than-predicted mobility of SREBPs on SDS gels
(41). One possibility is that residues within the Ser-rich domain
(Fig. 3) undergo cell-type-specific modifications. For example,
this region of rat SREBP2gc contains up to 10 potential Ser
phosphorylation sites (data not shown). A function for this
region of the N terminus has not been defined.
Relationship between SREBP2gc and PACH1. These studies
were initiated by the search for the DNA binding protein
PACH1, which recognizes the direct repeat sequences within
the proenkephalin GCP1 element (26). Like PACH1,
SREBP2gc is up-regulated in pachytene spermatocytes and
round spermatids. To determine whether SREBP2gc is in fact
PACH1, we first expressed rat SREBP2gc in bacteria and ex-
amined its DNA binding properties in Southwestern assays
(Fig. 11A). The bacterially expressed protein was able to bind
to both GCP1 and SRE-1 DNA probes, and this binding was
dependent on the relevant core recognition sequences in both
cases. Thus, rat SREBP2gc specifically binds to the GCP1
repeat elements, consistent with the isolation of its cDNA
based on this property. The GCP1 repeat element (CTCCAG)
and the SRE-1 core sequence (ATCACCCCAC) are not
highly homologous. However, SREBPs recognize a diverse
array of DNA sequences that frequently contain CCA (43),
which is present in the GCP1 repeat. In fact, a CCAG se-
quence forms part of the SREs for squalene synthase and
glycerol-3-phosphate acyltransferase (43). These similarities
could explain the ability of SREBP2gc to bind this proen-
kephalin germ line promoter element.
To examine further the possible identity between SREBP2gc
and PACH1, comparative Southwestern blots were performed
with rat nuclear extracts and the GCP1 and SRE-1 DNA
probes (Fig. 11B). For both probes, an 
55-kDa binding pro-
tein was identified in mouse testis and adult male germ cells in
equal abundance, but not in liver. No binding was seen in germ
cells with mutated versions of these probes (data not shown).
This finding suggested that SREBP2gc was the predominant
GCP1 binding protein in adult spermatogenic cells, at least as
detected by Southwestern assay. However, different results
were obtained with EMSAs. The PACH1 complex, as detected
with the GCP1 probe (26), was specifically competed by excess
amounts of the homologous sequence, but was not by
GCP1mut containing mutations in the direct repeat elements
(Fig. 11C). Importantly, SRE-1 sequences, which compete well
for SREBP2gc binding to the SRE-1 probe in EMSAs (Fig.
7B), were unable to displace PACH1 binding to the GCP1
probe (Fig. 11C). In reciprocal experiments, GCP1 sequences
did not compete more strongly than SRE-1 sequences for
binding of germ cell extracts to an SRE-1 probe (data not
shown). Finally, SREBP2gc was unable to stimulate the rat
proenkephalin germ line promoter in cotransfection experi-
ments with K293 cells (data not shown).
These results indicate that, while SREBP2gc is capable of
binding to GCP1 sequences, it does not by itself account for
the PACH1 DNA binding activity present in adult spermato-
genic cells. Based on Southwestern results, PACH1 and
SREBP2gc may be distinct proteins having very similar sizes
and germ cell abundances. Alternatively, PACH1 may be
present in considerably lower concentrations than SREBP2gc
in spermatogenic cells or may exist as a multimer of noniden-
tical subunits, such that SREBP2gc is the major GCP1 binding
protein detected on Southwestern blots. The possibility that
FIG. 11. Comparative properties of SREBP2gc and PACH1.
(A) Southwestern assay of bacterially expressed SREBP2gc protein.
Bacterial extracts (7 g) were assayed by using wild-type or mutant
GCP1 or SRE-1 probes (shown below the lanes). The glutathione
S-transferase (GST) fusion protein is predicted to be 
68 kDa in size
(29 kDa for GST plus 39 kDa for the SREBP2gc fragment). A non-
specific 70-kDa band (asterisk) was also detected with the GCP1
probe. (B) Southwestern analysis of SRE-1 and GCP1 binding proteins
in rat spermatogenic cells and tissues. Five micrograms (each) of
nuclear extracts from rat liver (Li), testis (Te), and enriched spermat-
ogenic cells from adult rat testis (Gc) was used. (C) EMSA of GCP1
binding proteins in rat spermatogenic cells. One microgram of nuclear
extracts of adult rat spermatogenic cells was examined with a GCP1
DNA probe. Competition experiments were performed with excess
unlabeled GCP1, SRE-1, and mutated GCP1 DNAs. The PACH1
complex is shown by an asterisk.
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SREBP2gc is a component of a heterocomplex that binds
GCP1 much more avidly than SRE-1 sequences cannot be
ruled out at this time.
DISCUSSION
These studies describe the identification of a novel member
of the SREBP family in spermatogenic cells that possesses
unique properties not found in its somatic counterpart. In
particular, SREBP2gc is synthesized as a soluble and con-
stitutively active transcription factor that bypasses the sterol-
regulated, proteolysis-dependent mechanisms, which limit its
expression in somatic cells (Fig. 12). Thus, novel, sterol-inde-
pendent mechanisms have evolved to regulate the expres-
sion of the SREBP2 transcription factor in male germ cells.
SREBP2gc is expressed in a stage-dependent manner during
spermatogenesis, with the highest levels occurring during the
later transcriptionally active stages, namely pachytene sper-
matocytes and round spermatids. Apparently this factor does
not continue to function in mature sperm (e.g., in DNA pack-
aging or male pronuclear transcription during early embryo-
genesis). Its stage-dependent expression is controlled at the
mRNA level, at least in part, with RNA splicing apparently
playing a predominant role based on analogy with the mutant
SREBP2 from hamster SRD-3 cells (53). In fact, the SRD-3
mutant protein apparently arose by usurping an alternative
splicing mechanism that normally is predominant in male germ
cells and is an infrequent event in somatic cells. Alternative
splicing is a common mechanism for generating cell-specific
mRNAs during spermatogenesis (51), including that for the
germ cell-specific isoform of the CREM transcription factor,
CREM (13). The mechanisms controlling cell- and stage-
specific regulation of RNA splicing during spermatogenesis
remain unclear. The germ cell protein RBM has been impli-
cated as a potential participant in these processes (12). Since
SREBP2 can activate its own promoter, at least in human
somatic cells (39), SREBP2gc also may regulate its own ex-
pression at the transcriptional level during spermatogenesis.
For example, this mechanism could contribute to the increased
levels of total SREBP2 transcripts observed in haploid germ
cells. However, whether mRNAs for SREBP2gc and SREBP2p
arise from a common promoter has not been determined,
although they clearly share common 5-UTR sequences.
The present findings raise important questions about the
role of SREBP2 and its target genes during spermatogenesis.
In particular, why do spermatogenic cells express a novel, ste-
rol-insensitive form of SREBP2? It is our hypothesis that gen-
eration of SREBP2gc provides a mechanism by which sper-
matogenic cells can regulate SREBP2-dependent genes in
selected developmental stages that would otherwise not be
possible with the standard sterol-regulated feedback pathway.
That is, developmentally regulated synthesis of an alternative
transcript encoding a soluble, constitutively active SREBP2
isoform permits its preferential function in specific germ cell
stages, which could not be readily achieved via a sterol-depen-
dent inhibitory mechanism. Furthermore, this stage-specific
function during later spermatogenesis is limited to SREBP2,
since expression of SREBP1 declines dramatically during this
process, and no novel isoform is apparent. This suggests that
target genes for SREBP2, as opposed to SREBP1, may be
particularly important during spermatogenesis. Based on struc-
tural similarities, the properties of SREBP2gc are predicted to
be identical to those of the mutant SREBP2 protein expressed
in SRD-3 cells. In addition to being constitutively active, the
protein from SRD-3 cells repressed the cleavage of SREBP
precursor proteins, apparently by inhibiting cleavage enzyme
expression or activity (53). Thus, SREBP2gc also may repress
the processing of the relatively small amounts of SREBP pre-
cursors present in adult spermatogenic cells.
Previous studies suggested that SREBPs were not involved
in the regulation of cholesterol biosynthetic genes during sper-
matogenesis (38). This was based in part on the fact that these
genes are typically regulated in a coordinate manner by sterols,
and this is not the case during spermatogenesis (46). The
present findings provide an alternative explanation for the
apparent sterol independence of SRE-containing target gene
expression in male germ cells: regulation by an SREBP isoform
that is not sensitive to sterol concentrations. In fact, a recent
study of squalene synthase gene expression in liver and testis
provides direct support for this (8). While squalene synthase
mRNA was highly regulated by dietary cholesterol levels in
liver, no such regulation was observed for its testicular
mRNAs. This is consistent with the regulation of the squalene
synthase promoter via its SRE sequences in both tissues, in
liver via standard sterol inhibition of SREBP2p cleavage to
form mature SREBP2, and in testis or spermatogenic cells via
stage-specific, sterol-independent activity of SREBP2gc.
Critical questions are the nature of the target genes regu-
lated by SREBP2gc during meiotic and early haploid stages
and the functional importance of SREBP2gc transcriptional
effects for spermatogenesis. Cholesterol is essential for normal
membrane structure and signaling and as a precursor for ste-
roid hormones and bile acids, and it also plays a highly spe-
FIG. 12. Sterol-insensitive regulation of promoters in meiotic and
early haploid spermatogenic cells by SREBP2gc. SREBP2gc bypasses
the SCAP-dependent, sterol-regulated proteolytic processing pathway
and directly enters the nucleus to regulate target genes in a constitutive
manner.
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cialized role in sperm function. In order for sperm to undergo
the acrosome reaction during fertilization, several cellular
modifications must first occur that are collectively referred to
as “capacitation.” A major initiating event in this process is the
loss of cholesterol from the sperm outer membrane (9). This
may involve altered partitioning of lipid rafts necessary for
membrane signaling events (50). Thus, incorporation of the
correct amounts of cholesterol into the cell membrane of ma-
turing sperm is critical for controlling the fertilization process.
Adult spermatogenic cells contain considerable concentrations
of free and total cholesterol (greater than those in Sertoli cells)
(2), and the expression of several genes involved in the cho-
lesterol biosynthetic pathway increases during male germ cell
maturation. These include the mRNAs for CYP51 and farnesyl
pyrophosphate synthetase, both of which are up-regulated in
round spermatids (38, 47), and squalene synthase mRNA,
which is expressed at similar levels in pachytene spermatocytes
and round spermatids (38, 46). Other SREBP targets increase
in the testis with maturation, which at least suggests their
expression in later stages of spermatogenesis. These include
the mRNAs for LDLR, HMG coenzyme A (CoA) synthase,
HMG CoA reductase, and enzymatic activities for ATP citrate
lyase and acetyl-CoA carboxylase (1, 29, 30). Thus, stage-de-
pendent regulation of cholesterol and lipid biosynthetic genes
is likely to be an important consequence of SREBP2gc expres-
sion during spermatogenesis. A complete analysis of the ex-
pression patterns of known SREBP2 target genes in specific
germ cell stages is clearly warranted.
The precise impact of the expression of cholesterol biosyn-
thetic genes and other potential SREBP2gc-regulated targets
on spermatogenesis remains to be determined. Cholesterol
synthesis increases during germ cell maturation in prepubertal
pachytene spermatocytes (37). However, no further increase
was observed in adult pachytene spermatocytes and round
spermatids, when SREBP2gc remains elevated. This may indi-
cate that, in addition to cholesterol, SREBP2gc is important
for regulating the synthesis of other lipids in later spermato-
genic stages. For example, the mevalonate pathway, which is
regulated by SREBP2 and is required for cholesterol synthesis,
also provides substrate for the synthesis of farnesyl pyrophos-
phate used for protein prenylation, dolichol phosphate re-
quired for protein glycosylation, and heme A and ubiquinone,
which are involved in mitochondrial electron transport (16). It
is noteworthy that the synthesis of dolichol phosphate was
reported to increase in both mouse pachytene spermatocytes
and round spermatids (37), and protein farnesyltransferase
transcripts increase during hamster spermatid maturation (33).
Farnesyl pyrophosphate synthetase mRNA is also specifically
enriched in haploid round spermatids (48). Furthermore, the
sterol product of the CYP51 enzyme is converted in the testis
to 4,4-dimethyl-5	-cholesta-8,24-diene-3-ol (also known as
“T-MAS,” for “testicular meiosis-activating sterol”), which can
induce meiosis in oocytes and has been implicated as an en-
dogenous regulator of spermatocyte maturation (45). The lev-
els of T-MAS increase with testicular development along with
the levels of CYP51 mRNA (46). These various observations
suggest that SREBP2gc may regulate the synthesis of multiple,
key lipid products important for completion of male meiosis
and spermiogenesis.
These studies raise an important issue regarding the basis
for the differential stage dependence of SREBP target gene
expression during spermatogenesis. As noted above, farnesyl
pyrophosphate synthetase and CYP51 mRNAs are specifically
up-regulated in round spermatids, while squalene synthase
transcripts increase to similar levels in pachytene spermato-
cytes and round spermatids (48). Transcriptional coregulators
such as Sp1, CREB/CREM, and NF-Y are required for opti-
mal transactivation by SREBPs (11), and both Sp1 and CREM
are expressed in a stage-dependent manner in meiotic and
early haploid stages (13, 36). This suggests that stage-specific
expression or activity of SREBP2gc coregulators may contrib-
ute to the differential regulation of SREBP2gc gene targets
during spermatogenesis. For example, the CYP51 gene is ac-
tivated by CREM, and is not expressed in round spermatids of
CREM-deficient mice (38). Based on this, it was suggested
that up-regulation of the CYP51 gene in round spermatids was
determined solely by CREM. In contrast, the present findings
argue that both CREM and SREBP2 are important for CYP51
expression in haploid germ cells. Thus, to fully understand
SREBP2gc function during spermatogenesis, it will be impor-
tant to determine the patterns of expression of various coregu-
lators and target genes for SREBP2gc in purified spermato-
genic cell stages.
The highly specialized differentiation and cell-specific tran-
scription occurring during spermatogenesis also raise the pos-
sibility that SREBP2gc regulates novel, cell-type-specific genes
in male germ cells. This may in part involve interactions with
unique spermatogenic cell coregulators yet to be identified.
Potentially novel posttranslational modification of SREBP2gc
during spermatogenesis could contribute to its germ cell-spe-
cific transcriptional properties, although this aspect requires
further investigation. Studies in which the function of
SREBP2gc is disrupted in vivo should prove extremely infor-
mative in determining the roles of this transcription factor and
its various target genes and coregulators during spermatogen-
esis.
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